$0.104000
-0.0039-3.61%
At close: -
$0.100000
-0.0040-3.85%
After Hours: 7:59 PM EDT
Comments
Loading...
Conduit Pharmaceuticals (NASDAQ:CDT) Stock, Earnings Estimates, EPS, And Revenue
Conduit Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.070
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Conduit Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Conduit Pharmaceuticals (CDT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Conduit Pharmaceuticals (CDT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Conduit Pharmaceuticals (NASDAQ:CDT) reporting earnings?
Conduit Pharmaceuticals (CDT) is scheduled to report earnings on February 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Conduit Pharmaceuticals (NASDAQ:CDT)?
The Actual EPS was $-0.07, which missed the estimate of $0.00.
What were Conduit Pharmaceuticals’s (NASDAQ:CDT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.